BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18625718)

  • 1. Genome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complex.
    Thillainadesan G; Isovic M; Loney E; Andrews J; Tini M; Torchia J
    Mol Cell Biol; 2008 Oct; 28(19):6066-77. PubMed ID: 18625718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex.
    Thillainadesan G; Chitilian JM; Isovic M; Ablack JN; Mymryk JS; Tini M; Torchia J
    Mol Cell; 2012 Jun; 46(5):636-49. PubMed ID: 22560925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
    Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
    Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence.
    Cowger JJ; Zhao Q; Isovic M; Torchia J
    Oncogene; 2007 May; 26(23):3378-86. PubMed ID: 17130829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines.
    Rich JN; Zhang M; Datto MB; Bigner DD; Wang XF
    J Biol Chem; 1999 Dec; 274(49):35053-8. PubMed ID: 10574984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B).
    Feng XH; Liang YY; Liang M; Zhai W; Lin X
    Mol Cell; 2002 Jan; 9(1):133-43. PubMed ID: 11804592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-beta1-induced expression of p15/INK4B.
    Frost SJ; Simpson DJ; Farrell WE
    Mol Cell Endocrinol; 2001 May; 176(1-2):29-37. PubMed ID: 11369440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oct-1 is involved in the transcriptional repression of the p15(INK4b) gene.
    Hitomi T; Matsuzaki Y; Yasuda S; Kawanaka M; Yogosawa S; Koyama M; Tantin D; Sakai T
    FEBS Lett; 2007 Mar; 581(6):1087-92. PubMed ID: 17316622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ZNF217 oncogene is a candidate organizer of repressive histone modifiers.
    Banck MS; Li S; Nishio H; Wang C; Beutler AS; Walsh MJ
    Epigenetics; 2009 Feb; 4(2):100-6. PubMed ID: 19242095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer.
    Baumgart S; Glesel E; Singh G; Chen NM; Reutlinger K; Zhang J; Billadeau DD; Fernandez-Zapico ME; Gress TM; Singh SK; Ellenrieder V
    Gastroenterology; 2012 Feb; 142(2):388-98.e1-7. PubMed ID: 22079596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus.
    Kia SK; Gorski MM; Giannakopoulos S; Verrijzer CP
    Mol Cell Biol; 2008 May; 28(10):3457-64. PubMed ID: 18332116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear Respiratory Factor-1, a Novel SMAD4 Binding Protein, Represses TGF-β/SMAD4 Signaling by Functioning as a Transcriptional Cofactor.
    Rajasekaran N; Song K; Lee JH; Wei Y; Erkin ÖC; Lee H; Shin YK
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase 3 represses p15(INK4b) and p21(WAF1/cip1) transcription by interacting with Sp1.
    Huang W; Tan D; Wang X; Han S; Tan J; Zhao Y; Lu J; Huang B
    Biochem Biophys Res Commun; 2006 Jan; 339(1):165-71. PubMed ID: 16298343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B.
    Datto MB; Hu PP; Kowalik TF; Yingling J; Wang XF
    Mol Cell Biol; 1997 Apr; 17(4):2030-7. PubMed ID: 9121451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway.
    Warner BJ; Blain SW; Seoane J; Massagué J
    Mol Cell Biol; 1999 Sep; 19(9):5913-22. PubMed ID: 10454538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Snail associates with EGR-1 and SP-1 to upregulate transcriptional activation of p15INK4b.
    Hu CT; Chang TY; Cheng CC; Liu CS; Wu JR; Li MC; Wu WS
    FEBS J; 2010 Mar; 277(5):1202-18. PubMed ID: 20121949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
    Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
    Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance and potential drug target of p15INK4B in multiple myeloma.
    Li J; Bi L; Lin Y; Lu Z; Hou G
    Drug Des Devel Ther; 2014; 8():2129-36. PubMed ID: 25382971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.